Annual Reports

 
Quarterly Reports

 
8-K

  • 8-K (Aug 20, 2014)
  • 8-K (Aug 14, 2014)
  • 8-K (Jul 30, 2014)
  • 8-K (Jul 25, 2014)
  • 8-K (Jul 10, 2014)
  • 8-K (May 16, 2014)

 
Other

QUESTCOR PHARMACEUTICALS 8-K 2009

Documents found in this filing:

  1. 8-K
  2. Ex-99.1
  3. Graphic
  4. Graphic
e8vk
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 9, 2009
QUESTCOR PHARMACEUTICALS, INC.
(Exact Name of Registrant as Specified in Charter)
         
California   001-14758   33-0476164
(State or Other Jurisdiction   (Commission File Number)   (I.R.S. Employer
of Incorporation)       Identification No.)
     
3260 Whipple Road Union City, California   94587
(Address of Principal Executive Offices)   (Zip Code)
Registrant’s telephone number, including area code: (510) 400-0700
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


TABLE OF CONTENTS

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 9.01 Financial Statement and Exhibits
EX-99.1


Table of Contents

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On October 9, 2009, the Board of Directors of Questcor Pharmaceuticals, Inc. (the “Company”) appointed Gregg A. Lapointe, C.P.A., M.B.A., as a director of the Company. Mr. Lapointe will serve on the Compensation Committee of the Board of Directors. As a director, Mr. Lapointe will participate in the Company’s 2004 Non-Employee Directors’ Equity Incentive Plan (the “Plan”).
A copy of the press release announcing the appointment of Mr. Lapointe to the Board of Directors and containing Mr. Lapointe’s biographical information is filed as Exhibit 99.1 hereto and incorporated by reference herein.
Item 9.01. Financial Statements and Exhibits.
     ( c) Exhibits.
         
Exhibit No.   Description
       
 
  99.1    
Questcor Pharmaceuticals, Inc. press release dated October 12, 2009.

 


Table of Contents

SIGNATURES
     Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
Date: October 14, 2009  QUESTCOR PHARMACEUTICALS, INC.
 
 
  By:   /s/ Gary M. Sawka    
    Gary M. Sawka   
    Senior Vice President, Finance, and
Chief Financial Officer 
 

 


Table of Contents

         
EXHIBIT INDEX
         
Exhibit No.   Description
       
 
99.1      
Questcor Pharmaceuticals, Inc. press release dated October 12, 2009.

 

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki